September 12, 2019
BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized,...
Source URL: https://www.prnewswire.com:443/news-releases/strekin-ag-announces-completion-of-patient-recruitment-in-the-restore-phase-3-clinical-study-of-str001-300915265.html
|
